Laxkair Syrup
By Laxkair
Rx
100ml Syrup in a Bottle

Composition
Sodium Picosulfate(5mg/5ml)

Manufacturer - PDC Healthcare
PDC Healthcare, 27770 N. Entertainment Drive, Suite 200, Valencia, California, 91355

Expires on or after
October, 2025

liver
If you have liver disease or impairment, it is important to consult with your doctor before using Laxkair Syrup. Limited information is available regarding the use of this syrup in patients with liver issues, so seeking guidance from a healthcare professional is recommended to ensure your safety and wellbeing. Please consult your doctor before taking Laxkair Syrup if you have liver impairment or liver disease.

kidney
Limited information is available on using Laxkair Syrup in patients with kidney disease. Consult your doctor before using if you have kidney impairment.

alcohol
It is advised not to drink alcohol while taking Laxkair Syrup due to potential interactions. Consult your doctor for more information on alcohol consumption with Laxkair Syrup.

driving
When taking Laxkair Syrup, it is uncertain if it impacts driving ability. Refrain from driving if you have symptoms that hinder focus and reaction time. The 100ml Oral Solution has minimal effect on driving.

pregnancy
Laxkair Syrup is believed to be safe in pregnancy based on animal studies with few negative effects on the baby. Limited human studies are available. It is advisable to consult your doctor prior to using Laxkair Syrup during pregnancy; your doctor will weigh the benefits against the risks.

breastfeeding
Laxkair Syrup is considered safe for breastfeeding based on limited data showing no significant risk to the baby. Consult your doctor before using Laxkair Syrup while breastfeeding to determine its safety for nursing mothers.
Habit Forming | No |
Chemical Class | Diphenylmethane Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Stimulant laxatives/purgative |
₹39
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024